Targeting α-Synuclein in Parkinson's Disease: Progress Towards the Development of Disease-Modifying Therapeutics.
- Published in:
- Drugs, 2019, v. 79, n. 8, p. 797, doi. 10.1007/s40265-019-01104-1
- By:
- Publication type:
- Article
Works matching IS 00126667 AND DT 2019 AND VI 79 AND IP 8
Results: 10
1
2
Dacomitinib in the Management of Advanced Non-Small-Cell Lung Cancer.
- Published in:
- Drugs, 2019, v. 79, n. 8, p. 823, doi. 10.1007/s40265-019-01115-y
- By:
- Publication type:
- Article
3
Correction to: Pegaspargase: A Review in Acute Lymphoblastic Leukaemia.
- Published in:
- 2019
- By:
- Publication type:
- Correction Notice
4
Risankizumab: First Global Approval.
- Published in:
- Drugs, 2019, v. 79, n. 8, p. 893, doi. 10.1007/s40265-019-01136-7
- By:
- Publication type:
- Article
5
Teriflunomide: A Review in Relapsing–Remitting Multiple Sclerosis.
- Published in:
- Drugs, 2019, v. 79, n. 8, p. 875, doi. 10.1007/s40265-019-01135-8
- By:
- Publication type:
- Article
6
Peficitinib: First Global Approval.
- Published in:
- Drugs, 2019, v. 79, n. 8, p. 887, doi. 10.1007/s40265-019-01131-y
- By:
- Publication type:
- Article
7
Tafamidis: A Review in Transthyretin Amyloidosis with Polyneuropathy.
- Published in:
- Drugs, 2019, v. 79, n. 8, p. 863, doi. 10.1007/s40265-019-01129-6
- By:
- Publication type:
- Article
8
Does the Administration of Sevelamer or Nicotinamide Modify Uremic Toxins or Endotoxemia in Chronic Hemodialysis Patients?
- Published in:
- Drugs, 2019, v. 79, n. 8, p. 855, doi. 10.1007/s40265-019-01118-9
- By:
- Publication type:
- Article
9
Adverse Effects Associated with Long-Term Administration of Azole Antifungal Agents.
- Published in:
- Drugs, 2019, v. 79, n. 8, p. 833, doi. 10.1007/s40265-019-01127-8
- By:
- Publication type:
- Article
10
Drugs in Development for Acute Kidney Injury.
- Published in:
- Drugs, 2019, v. 79, n. 8, p. 811, doi. 10.1007/s40265-019-01119-8
- By:
- Publication type:
- Article